相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats
G. Youcef et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
No benefit from the obesity paradox for diabetic patients with heart failure
Elisabet Zamora et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Update on Obesity and Obesity Paradox in Heart Failure
Carl J. Lavie et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2016)
Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality
Karine R. Sahakyan et al.
ANNALS OF INTERNAL MEDICINE (2015)
Obesity and the Obesity Paradox in Heart Failure
Pritha P. Gupta et al.
CANADIAN JOURNAL OF CARDIOLOGY (2015)
Mineralocorticoid Receptor Antagonism Treats Obesity-Associated Cardiac Diastolic Dysfunction
Shawn B. Bender et al.
HYPERTENSION (2015)
Excess Body Mass Index- and Waist Circumference-Years and Incident Cardiovascular Disease: The CARDIA Study
Jared P. Reis et al.
OBESITY (2015)
Mineralocorticoid receptors in the heart: lessons from cell-selective transgenic animals
Morag J. Young et al.
JOURNAL OF ENDOCRINOLOGY (2015)
Circulating Aldosterone and Natriuretic Peptides in the General Community Relationship to Cardiorenal and Metabolic Disease
Alessia Buglioni et al.
HYPERTENSION (2015)
International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction
Soren L. Kristensen et al.
CIRCULATION (2015)
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
Marc A. Pfeffer et al.
CIRCULATION (2015)
Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice
Andrea Armani et al.
FASEB JOURNAL (2014)
Body Mass Index and Mortality in Acutely Decompensated Heart Failure Across the World
Ravi Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Obesity and Cardiovascular Diseases
Carl J. Lavie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society
Michael D. Jensen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Simultaneous Characterization of Metabolic, Cardiac, Vascular and Renal Phenotypes of Lean and Obese SHHF Rats
Gina Youcef et al.
PLOS ONE (2014)
Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease
Marjorie Bastien et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2014)
Ectopic visceral fat: A clinical and molecular perspective on the cardiometabolic risk
Patrick Mathieu et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2014)
Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade
Wojciech Kosmala et al.
HEART (2013)
The obesity paradox in heart failure: Is etiology a key factor?
Elisabet Zamora et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Obesity and Heart Failure
Giovanni Pergola et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2013)
Impact of Obesity and the Obesity Paradox on Prevalence and Prognosis in Heart Failure
Carl J. Lavie et al.
JACC-HEART FAILURE (2013)
Left Ventricular Function Impairment in Patients With Normal-Weight Obesity Contribution of Abdominal Fat Deposition, Profibrotic State, Reduced Insulin Sensitivity, and Proinflammatory Activation
Wojciech Kosmala et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2012)
Oxidative Stress in the Cardiorenal Metabolic Syndrome
Adam Whaley-Connell et al.
CURRENT HYPERTENSION REPORTS (2012)
The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism
Vincenzo Marzolla et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Antiadipogenic Effects of the Mineralocorticoid Receptor Antagonist Drospirenone: Potential Implications for the Treatment of Metabolic Syndrome
Massimiliano Caprio et al.
ENDOCRINOLOGY (2011)
Waist Circumference, Body Mass Index, and Survival in Systolic Heart Failure: The Obesity Paradox Revisited
Adrienne L. Clark et al.
JOURNAL OF CARDIAC FAILURE (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Joint Effects of Physical Activity, Body Mass Index, Waist Circumference, and Waist-to-Hip Ratio on the Risk of Heart Failure
Gang Hu et al.
CIRCULATION (2010)
Aldosterone: Role in the Cardiometabolic Syndrome and Resistant Hypertension
Adam Whaley-Connell et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2010)
Aldosterone and inflammation
Kimberly C. Gilbert et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
The Obesity Paradox, Weight Loss, and Coronary Disease
Carl J. Lavie et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice
Ayumu Hirata et al.
CARDIOVASCULAR RESEARCH (2009)
Adiposity and Incidence of Heart Failure Hospitalization and Mortality A Population-Based Prospective Study
Emily B. Levitan et al.
CIRCULATION-HEART FAILURE (2009)
Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-γ, and proinflammatory adipokines
Christine Guo et al.
CIRCULATION (2008)
Prevention of heart failure - A scientific statement from the American Heart Association councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; Quality of care and outcomes research interdisciplinary working group; and functional genomics and translational biology interdisciplinary working group
Douglas D. Schocken et al.
CIRCULATION (2008)
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients
Gian Paolo Rossi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors - The framingham offspring study
Erik Ingelsson et al.
CIRCULATION (2007)
Body mass index and prognosis in patients with chronic heart failure - Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
Satish Kenchaiah et al.
CIRCULATION (2007)
Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis
Massimiliano Caprio et al.
FASEB JOURNAL (2007)
Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies
B Pitt
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
Obesity and the risk of heart failure
S Kenchaiah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Mechanisms of disease - Aldosterone in congestive heart failure
KT Weber
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The EPHESUS trial: Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction
B Pitt et al.
CARDIOVASCULAR DRUGS AND THERAPY (2001)
分享论文
